At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Carbon Monoxide Breath Sensor System (COBSS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Carbon Monoxide Breath Sensor System (COBSS) Performance, Human Factors, and Usability Assessment in a Single Visit
In Brief
A clinical study evaluating Carbon Monoxide Breath Sensor System (COBSS) and Bedfont - Micro+™ Smokerlyzer® for Smoking, Tobacco. Completed, enrolled 70 participants across 1 site.
Detailed Summary
Prospective, open label, single center clinical study enrolling 70 subjects to study Performance, Human Factors, and Usability for the Carbon Monoxide Breath Sensor System (COBBS)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking, Tobacco
CountriesUnited States
CollaboratorsUserWise, LLC
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
Primary CompletionMar 2017
First PostedMay 2017
Study CompletionAug 2017
TodayJul 2026
First PostedMay 11, 2017
Enrollment StartFeb 2, 2017
Primary CompletionMar 15, 2017
Study CompletionAug 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.1 years ago
Interventions
Carbon Monoxide Breath Sensor System (COBSS)device
Carbon Monoxide Breath Sensor System (COBSS): Device to measure carbon monoxide levels in one's breath and inform the user.
Bedfont - Micro+™ Smokerlyzer®device
Bedfont - Micro+™ Smokerlyzer® : Predicate Device to measure carbon monoxide levels in one's breath.